Flow cytometric analysis of Human CD203c expression on human PBMC (human peripheral blood mononuclear cell). Human PBMC were stained with FITC Mouse Anti-Human CD123 antibody and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Left panel) or SDT Alexa Fluor® 647 Mouse Anti-Human CD203c Antibody (Right panel) at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD203c |
Synonyms | Ectonucleotide pyrophosphatase/phosphodiesterase family member 3; E-NPP 3; NPP3; Alkaline phosphodiesterase I; Dinucleoside polyphosphatase; Nucleotide diphosphatase; Nucleotide pyrophosphatase (NPPase); Phosphodiesterase I beta (PD-Ibeta); Phosphodiesterase I/nucleotide pyrophosphatase 3; PDNP3; ENPP3 |
Location | Cell membrane |
Accession | O14638 |
Clone Number | S-2916 |
Antibody Type | Mouse mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | human PBMC |
Purification | Protein G |
Concentration | 0.2 mg/ml |
Conjugation | Alexa Fluor® 647 |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD203c, also known as ectonucleotide pyrophosphatase/phosphodiesterase-3 (E-NPP3), is a type II transmembrane protein belonging to the ectonucleotide pyrophosphatase/phosphodiesterase family. It is specifically expressed on basophil-committed progenitor cells and mature basophils, and to a lesser extent on tissue mast cells. CD203c is rapidly upregulated on the cell surface upon basophil activation, such as through cross-linking of the IgE receptor, making it a valuable activation marker for these cells. It plays a role in regulating the inflammatory response by hydrolyzing ATP, which helps suppress chronic allergic inflammation. Additionally, CD203c has been identified as a potential biomarker for basophilia in diseases like chronic myeloid leukemia (CML), where its expression levels correlate with disease severity and treatment response.
Picture
Picture
FC
